ClinicalTrials.Veeva

Menu

Electronic Triggers: Messaging After A1C EHR Alert

NYU Langone Health logo

NYU Langone Health

Status

Completed

Conditions

Diagnostic Tests
Hemoglobins

Treatments

Behavioral: MyChart message

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Studying subjects with HbA1C tests >10 and no follow-up test within 6 months and appointments scheduled in the next 60 days from data run date. Subjects who receive intervention message may be more likely to follow up with their provider to schedule a follow up HbA1C test.

Enrollment

2,403 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • MyChart active patients with HbA1C tests >10 and no follow-up test within 6 months and no appointments scheduled in the next 60 days from data run date

Exclusion criteria

  • Patients with a scheduled appointment within 60 days from time algorithm is run; hospital encounters; non English or Spanish patients as indicated by primary language in Epic

Trial design

2,403 participants in 2 patient groups

MyChart message
Description:
MyChart message subjects with high A1C blood tests to help manage their diabetes and prevent some of the complications caused by high sugars. The message recommends that they schedule a visit with their doctor who can recheck the blood test and help get their diabetes under control.
Treatment:
Behavioral: MyChart message
No MyChart message
Description:
No message

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems